SFX by Ex Libris Inc.

Title:	Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
Source:	Neuron [0896-6273] McGowan, Eileen yr:2005

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	MANDYBUR, THADDEUS I. "Cerebral Amyloid Angiopathy." Journal of Neuropathology and Experimental Neurology 45.1 (1986): 79-90.
description	2.	MANN, D. "Amyloid ? protein (A?) deposition: A?42(43) precedes A?40 in down Syndrome." Annals of neurology 37.3 (1995): 294-299.
description	3.	Yan, Y.. "Aβ40 Protects Non-toxic Aβ42 Monomer from Aggregation." Journal of molecular biology 369.4 (2007): 909-916.
description	4.	Vinters, H V V. "Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes." Stroke 14.6 (1983): 924-8.
description	5.	Lemere, C. "Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation." Neurobiology of disease 3.1 (1996): 16-32.
description	6.	Kim, J.. "Aβ40 inhibits amyloid deposition in vivo." The journal of neuroscience 27.3 (2007): 627-633.
description	7.	Holton, T. "Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view." Journal of neuropathology and experimental neurology 62.9 (2003): 885-98.
description	8.	Gilbert, J, J J J. "Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage.." Stroke 14.6 (1983): 915-23.
description	9.	Castellani, Rudy J J. "Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis." Neurobiology of Aging 25.5 (2004): 599-602.
description	10.	Revesz, T. "Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies." Acta Neuropathologica 118.1 (2009): 115-130.
description	11.	Polvikoski, T. "Apolipoprotein E, dementia, and cortical deposition of ?-amyloid protein." New England Journal of Medicine, The 333.19 (1995): 1242-7.
description	12.	Pfeifer, M. "Cerebral hemorrhage after passive anti-Abeta immunotherapy." Science 298.5597 (2002): 1379-1379.
description	13.	Tian, J. "Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease." Neuropathology and applied neurobiology 30.1 (2004): 46-56.
description	14.	Soffer, D. "Cerebral amyloid angiopathy--a disease or age-related condition." The Israel Medical Association journal 8.11 (2006): 803-6.
description	15.	Lifshitz, V. "Neuroprotective and Neurotoxic Properties of Glial Cells in the Pathogenesis of Alzheimer's Disease." Journal of Cellular and Molecular Medicine 12.3 (2008): 762-80.
description	16.	Thal, Dietmar Rudolf R. "Two types of sporadic cerebral amyloid angiopathy." Journal of neuropathology and experimental neurology 61.3 (2002): 282-93.
description	17.	Graeber, Manuel B. "Reanalysis of the first case of Alzheimer's disease." European archives of psychiatry and clinical neuroscience 249.Suppl 3 (1999): 10-13.
description	18.	Walsh, D.M. M. "Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo." Nature 416.6880 (2002): 535-539.
description	19.	Lockhart, A. "PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide- related cerebral amyloidosis." Brain 130.P10 (2007): 2607-15.
description	20.	Hashimoto, M. "Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases." NeuroMolecular Medicine 4.1 (2003): 21-36.